Transparency Market Research

Global Erythropoietin Stimulating Agent Market Key Trends & Industry Forecast 2015-2023

Transparency Market Research Report Added "Erythropoietin Stimulating Agent Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023"


Albany, NY -- (SBWIRE) -- 06/21/2017 -- GlobalErythropoietin stimulating agent market are driven by increasing number of patients suffering from anemia, anemia induced due to cancer, end stage renal disease (ESRD) and HIV treatment. In June 1989,Epoetin alfa was the first drug for EPO, manufactured by Amgen Inc. U.S FDA approved itunder the trade name "Epogen".The global market for erythropoietin drugs are expected to grow in near future as increased cases of cancer and renal problem haveregistered. With the expiration of Amgen's patent for Epogen, it has helped the production of other biosimilars EPO drugs. Hence, availability of many biosimilar drugs has renderedlow-cost option to the patients, therefore particularly, in the developing regions the adoption of EPO drugs have increased.

Obtain Report Details @

Blood carries oxygen which is required for a healthy body functioning. When the concentration of oxygen is reduced in the blood then an oxygen-sensing protein present in the kidney identifies the deficiency of oxygen gradient in the blood and then induces the EPO production,which then turns upon the erythroid cell line in the bone marrow to stimulate hematopoiesis and thus it response to the change in blood oxygen gradient. Endogenous erythropoietin (EPO) is a glycoprotein hematopoietic hormone, which is synthesized, in the renal tubules. EPO helps in controlling and regulating the mechanism of erythropoiesisin the bone marrow. Due to anemia and renal problem, the production of erythropoietin (EPO) istroubled, resulting into fatigue, weakness, shortness of breath, pale skin and insomnia.For treating anemia,chemotherapy induced anemia, renal disorders and others erythropoietin stimulating drugs (EPO) are used.For development of synthetic form of erythropoietin drugs such as epoetin alfa, epoetin beta, darbepoetin alfa, epoetin delta, epoetin omega and others with the help of improved recombinant DNA technology.Recombinant erythropoietin is an artificialformof natural erythropoietin. These are made by cloning the gene for erythropoietin. Among synthetic EPO'sepoetin alfa, epoetin beta, epoetin omega, epoetin delta and darbepoetin-alpha are used extensively. Epoetin delta is another recombinant EPO that is been used for treating patients with chronic kidney disease (CKD).

Based on product type erythropoietin stimulating agent can divided as Epoetin-alfa, Epoetin-beta, epoetin omega, epoetin delta and darbepoetin-alpha. Application of erythropoietin stimulating agents are classified as anemia, cancer chemotherapy, kidney disorders (ESRD and dialysis), antiretroviral treatment (ART) and others (neural disease and wound healing),

Some of the major players in erythropoietin stimulating agent market are Amgen Inc., Biocon, Celltrion, Inc., Hospira Inc., Intas Pharmaceuticals, Johnson & Johnson, Ranbaxy Laboratories Ltd., Roche, LG Life Sciences Ltd. and Teva Pharmaceutical Industries Ltd.

Fill the form for an exclusive sample of this report @

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Browse market research blog: